Costing – Immunization Economics

Home
About
Zero-dose
News & opportunities
Resources
Events

Home
Zero-dose
News & opportunities
Resources
Events
About

Costing

Tag

Supply, demand and use of economic evidence in vaccine policymaking in Africa: A scoping review

September 30, 20262026, Africa, Algeria, BCG, Benin, Burkina Faso, Burundi, Capacity building, Central African Republic, Chad, Cholera, Comoros, cost-effectiveness, Costing, DRC, Egypt, English, Enhancing the use of Economic Evidence in Vaccine Policy Making in Africa, Equatorial Guinea, ETEC, Ethiopia, Financing, Gabon, Gambia, Ghana, Global/multi-country, Guinea, Guinea-Bissau, Health technology assessment, Hepatitis, Hib, HIV, HPV, KEMRI-Wellcome Trust Research Programme, Kenya, Liberia, Libya, Lund University, Malaria, Malawi, Mali, Measles, Meningitis, Morocco, Mozambique, Niger, Nigeria, Peer reviewed article, Penta, Pneumococcal, Polio, Prioritization, Review, Rotavirus, Routine schedule, RSV, Rwanda, Senegal, Shigella, Somalia, South Africa, South Sudan, Tanzania, TB, Tunisia, Typhoid, Uganda, University of Oxford, University of Washington, University of Zambia, Wellcome Trust, Zambia, Zimbabwe

Cost-effectiveness and budget impact analyses of introducing typhoid conjugate vaccine into Indonesia’s national immunisation program

September 14, 20262026, Asia, Budget impact, Campaigns, cost-effectiveness, Costing, English, Financing, Gates Foundation, Indonesia, Murdoch Children’s Research Institute, New vaccine introduction, Peer reviewed article, Prioritization & optimization, Routine immunization, Typhoid, Universitas Gadjah Mada, University of Melbourne, Yale University

Estimating the cost of reaching zero dose children: a guide for the Zero-Dose Learning Agenda (ZDLA)

September 9, 2026Costing, Methodological guidance/tool, Zero Dose

Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants

August 21, 20262026, Accsight, Africa, Ain Shams University, Alexandria University, budget impact analysis, Cairo University, Costing, Egypt, English, Financing, New vaccine introduction, Peer reviewed article, Pfizer, RSV

Applying a human-centered design approach to increase immunization coverage and reduce the number of zero-dose children in Tshopo Province, Democratic Republic of the Congo: A costing analysis

June 23, 20262026, Africa, Costing, Demand generation, Democratic Republic of the Congo, English, Human-centered design, Improving coverage, PATH, Peer reviewed article, Private sector, Routine immunization, Routine schedule, Zero Dose

Cost analysis of a nationwide typhoid conjugate vaccine campaign in Burkina Faso

June 18, 20262026, Africa, Burkina Faso, Campaigns, Costing, Davycas International, English, New vaccine introduction, PATH, Peer reviewed article, Study, Typhoid, Université Joseph Ki-Zerbo

Economic implications of switching to the hexavalent infant vaccine in animmunization program in India

June 18, 20262026, Asia, Costing, English, Gates Foundation, Gavi, George Institute For Global Health, Hexavalent vaccine, India, JSI India, Ministry of Health and Family Welfare India, New vaccine introduction, Peer reviewed article, Routine immunization, Study, University of New South Wales

Reconstruction of immunisation during conflict: A mixed-methods cohort evaluation of programme delivery and outcomes in Myanmar

June 11, 20262026, Asia, Chin Health Organization, Costing, Demand generation, English, Equity, Improving coverage, Karenni Nurses Association, Myanmar, Routine immunization, Routine schedule, Study, The Equity Initiative, University of California Irvine, Zero Dose

Mass vaccination with two-dose Oral cholera vaccine in vulnerable populations, using existing public health infrastructure from planning to delivery through multi-sectoral collaboration in West Bengal, India

May 26, 20262026, Asia, Campaigns, Cholera, Costing, English, ICMR-NIRBI, ICMR-Regional Medical Research Center North East, Improving coverage, India, Peer reviewed article, Study

Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov models

May 10, 20262026, Asia, China, Chinese Center for Disease Control and Prevention, cost-effectiveness, Costing, Covid-19, English, Harbin Medical University, Peer reviewed article, Prioritization & optimization, Vaccine, Value of Vaccines

1 2 3 … 51

Managed by

Website search

Search

Learn more

About
Contact
Get involved

Follow us

LinkedIn
Facebook
YouTube

Copyright Immunization Economics 2025. All rights reserved.

Donate to sustain the community of practice

For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.

Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.

Loading Comments...

Write a Comment...

Email

Name

Website